FTEA
FBT icon

Forty-three Eighteen Advisors’s First Trust NYSE Arca Biotechnology Index Fund FBT Stock Holding History

Forty-three Eighteen Advisors’s Portfolio FBT Stock Details FBT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		– Sell
-6,299
Closed -$1.26M – 84
2026
Q1 		$1.26M Buy
+6,299
New +$1.3M 0.95% 38

Other funds holding FBT

First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Wells Fargo
Wells Fargo San Francisco, California $617B AUM 30.33% 1-Year Est. Return
LPL Financial
LPL Financial San Diego, California $445B AUM 25.58% 1-Year Est. Return
Raymond James Financial
Raymond James Financial St Petersburg, Florida $369B AUM 28.27% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
Bessemer Group
Bessemer Group Woodbridge, New Jersey $72.7B AUM 39.36% 1-Year Est. Return
BFG
Berger Financial Group Plymouth, Minnesota $1.96B AUM 20.58% 1-Year Est. Return

Forty-three Eighteen Advisors's FBT Position: Q2 2026 in Review

Forty-three Eighteen Advisors sold out of First Trust NYSE Arca Biotechnology Index Fund (FBT) in Q2 2026, closing a stake of 6,299 shares — an estimated $1.26M sold.

Forty-three Eighteen Advisors first reported a position in FBT in Q1 2026 and held it in 1 quarter. The position peaked at $1.26M in Q1 2026. 339 funds tracked by Wall St. Rank hold FBT as of Q2 2026.

  • Forty-three Eighteen Advisors reported no remaining First Trust NYSE Arca Biotechnology Index Fund position as of Q2 2026 after selling out during the quarter.
  • Forty-three Eighteen Advisors sold 6,299 First Trust NYSE Arca Biotechnology Index Fund shares in Q2 2026, an estimated $1.26M.
  • Forty-three Eighteen Advisors first reported a position in First Trust NYSE Arca Biotechnology Index Fund in Q1 2026 and held it in 1 quarter.
  • Forty-three Eighteen Advisors's First Trust NYSE Arca Biotechnology Index Fund position peaked at $1.26M in Q1 2026.
  • 339 funds tracked by Wall St. Rank held First Trust NYSE Arca Biotechnology Index Fund as of Q2 2026.

Based on Forty-three Eighteen Advisors's 13F filing for Q2 2026, filed 30 Jul 2026.